PMV Pharma Announces Proposed Public Offering
PMV Pharmaceuticals (NASDAQ: PMVP) announced the launch of an underwritten public offering, which includes common stock and accompanying warrants. The company may also offer pre-funded warrants to certain investors in lieu of shares. All securities will be sold directly by PMV Pharmaceuticals. However, specific details such as the size or terms of the offering have not yet been finalized and remain subject to market conditions. TD Cowen is serving as the sole book-running manager for this offering. The move reflects ongoing efforts by PMV Pharmaceuticals to raise capital through equity financing amid evolving financial strategies.
Tickers: $PMVP